当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:91.41亿  总市值:92.64亿
流通股本:11.92亿   总股本:12.08亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金9,022,543,571.866,115,765,143.183,139,521,365.3411,968,938,145.5
收到的税费返还44,364,483.6933,099,390.9726,331,264.86162,182,418.05
收到其他与经营活动有关的现金338,969,997.64261,383,962.46130,968,310.79499,253,005.47
经营活动现金流入的平衡项目0000
经营活动现金流入小计9,405,878,053.196,410,248,496.613,296,820,940.9912,630,373,569.02
购买商品、接受劳务支付的现金4,588,781,259.573,152,044,383.051,642,918,810.465,609,960,306.73
支付给职工以及为职工支付的现金1,323,279,434.27943,114,408.99578,508,332.871,732,765,953.94
支付的各项税费562,227,502.26419,227,750.31233,940,412.34828,612,702.77
支付其他与经营活动有关的现金1,610,539,628.31,154,136,866.65536,989,2142,393,297,997.49
经营活动现金流出的平衡项目0000
经营活动现金流出小计8,084,827,824.45,668,523,4092,992,356,769.6710,564,636,960.93
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,321,050,228.79741,725,087.61304,464,171.322,065,736,608.09
二、投资活动产生的现金流量:
收回投资收到的现金25,441,772.4724,500,00024,500,00075,660,631.06
取得投资收益收到的现金15,765,62315,765,6231,604,62314,827,500.04
处置固定资产、无形资产和其他长期资产收回的现金净额17,273,548.211,028,707.55716,566.6691,615,197.25
处置子公司及其他营业单位收到的现金净额22,973,359.654,172,121.374,172,121.3743,451,590.99
收到的其他与投资活动有关的现金9,289,331.888,679,569.38523,823.8515,000,524.59
投资活动现金流入的平衡项目0000
投资活动现金流入小计90,743,635.2154,146,021.331,517,134.88240,555,443.93
购建固定资产、无形资产和其他长期资产支付的现金248,846,829.76196,166,330.24150,899,019.9530,615,485.51
投资支付的现金200,000200,000200,000118,720,264.29
支付其他与投资活动有关的现金182,108,708.26181,566,008.2610,423,024.57170,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计431,155,538.02377,932,338.5161,522,044.47819,335,749.8
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-340,411,902.81-323,786,317.2-130,004,909.59-578,780,305.87
三、筹资活动产生的现金流量:
吸收投资收到的现金---323,009,601.13
其中:子公司吸收少数股东投资收到的现金---299,716,981.13
取得借款收到的现金2,668,152,438.582,077,152,438.581,402,152,438.584,605,538,254.63
收到其他与筹资活动有关的现金2,000,0002,000,000-1,188,656,603.77
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,670,152,438.582,079,152,438.581,402,152,438.586,117,204,459.53
偿还债务支付的现金2,385,400,0001,575,600,0001,000,200,0006,203,191,062.74
分配股利、利润或偿付利息支付的现金319,905,869.2282,007,014.4638,369,393.74381,245,646.5
支付其他与筹资活动有关的现金729,482,650.5645,498,770.55315,998,617.111,038,172,254.27
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,434,788,519.72,503,105,785.011,354,568,010.857,622,608,963.51
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-764,636,081.12-423,953,346.4347,584,427.73-1,505,404,503.98
四、汇率变动对现金及现金等价物的影响3,419,097.894,839,906.38-827,928.556,525,965.65
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额219,421,342.75-1,174,669.64221,215,760.91-11,922,236.11
加:期初现金及现金等价物余额1,165,149,054.961,165,149,054.961,165,149,054.961,177,071,291.07
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,384,570,397.711,163,974,385.321,386,364,815.871,165,149,054.96
补充资料:
净利润-431,107,180.61-491,419,477.85
资产减值准备-97,021,495.31-116,511,350.71
固定资产和投资性房地产折旧-447,557,232.8-887,915,709.96
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-447,557,232.8-887,915,709.96
无形资产摊销-70,434,899.84-141,192,652.32
长期待摊费用摊销-2,450,823.72-5,591,107.41
处置固定资产、无形资产和其他长期资产的损失-1,196,608.97-496,474.43
固定资产报废损失-1,942,738.03-1,559,533.62
公允价值变动损失--163,740.03-107,317,563.23
财务费用-111,695,748.72-283,847,672.93
投资损失--102,032,434.37--30,471,231.19
递延所得税--7,469,290.72-20,553,461.5
其中:递延所得税资产减少--14,924,167.37-22,514,217.87
递延所得税负债增加-7,454,876.65--1,960,756.37
存货的减少-70,790,448.42-19,033,543.1
经营性应收项目的减少--205,592,207.55--398,925,987.61
经营性应付项目的增加--202,878,820.95-362,177,126.31
其他-19,820,830.85-46,698,078.37
现金的期末余额-1,163,974,385.32-1,165,149,054.96
减:现金的期初余额-1,165,149,054.96-1,177,071,291.07
公告日期2023-10-282023-08-222023-04-252023-03-31
审计意见(境内)标准无保留意见
TOP↑